Cedric joined Sofinnova Partners in June 2018, bringing his 18 years of experience in life sciences investment banking. He is a partner on the Crossover team.
Cedric joined from Oddo BHF where he was managing director and head of healthcare in the corporate finance department. In 2017, Oddo BHF was the top ranked firm for European biotech equity capital market deals. Prior to this, he was director at Bryan Garnier & Co where he completed several sizable cross-border transactions, including Galapagos, DBV, Ablynx, and Celyad. In total, he has managed more than 2 billion euros in European healthcare transactions.